Kumar Venugopal
Chief Technology Officer at Zoetis
New York City Metropolitan Area, United States
About Kumar Venugopal
Kumar Venugopal is Chief Technology Officer at Zoetis. Location: New York City Metropolitan Area, United States.
I’m a business-focused IT executive with 25+ years in biopharma/life sciences and a passion for transforming organizations. My super power is in capturing significant cost savings and then leveraging those funds for strategic investments that drive business value, capabilities, efficiency, global growth, sustainability, and scalability. I have had oversight of Global Business Services and IT Shared Services, Enterprise Applications, Data and Digital Solutions, AI/ML Automation, SAFe Agile and DevOps Transformation, PMO, Enterprise Infrastructure, and IT M&A Integration. I currently serve as a CTO & SVP at Zoetis, heading up their Global Enterprise and User Organization, and I was recently appointed as the company’s AI/ML Champion. Prior to Zoetis, I was at Biogen as the Global Head of Enterprise Applications & User Support and Teva Pharmaceuticals as VP, Global Head, Division CIO, and other IT Leader roles and with Deloitte/CGI as a Senior Consultant and Lead Architect. Peers and team members describe me as a thoughtful, collaborative leader who is committed to developing and mentoring high-performance teams. I enjoy creating a culture of autonomy with accountability to attract top talent focused on change and innovation. My deep international background spanning India, Korea, the US, Europe, and Israel contributes to my dedication for building strong multi-cultural teams and for advancing meaningful DEI initiatives. Career Highlights ➺Generated $200M+ in value and cost savings by transforming global operating models for IT and business services encompassing Finance, HR, Manufacturing, R&D, Legal, Procurement, and Commercial functions ➺Scaled IT and Global Business Services by 2,400 FTEs, including the stand up of 4 legal entities and the build out of global Agile Development and Digital Delivery Centers in India and Eastern Europe ➺Delivered $25M+ in productivity savings and value impact by leading 120+ AI/ML Automation, Digital Innovation, and Data Science Optimization projects ➺Led M&A integration to attain Day 1 Readiness of IT infrastructure and security for Teva’s $39B acquisition of Actavis Generics
Skills
Additional experience
VP, Enterprise Applications (Data, Digital, AI, Global Platforms)
Biogen
April 2022 – July 2025
Education
- Bachelor of Science - BS, University of Missouri-Kansas City
- Master of Business Administration - MBA, Liberty University